Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug Review
Curr Oncol
.
2013 Apr;20(2):121-4.
doi: 10.3747/co.20.1315.
Authors
J S Hoch
1
,
M Sabharwal
Affiliation
1
Pharmacoeconomics Research Unit, Cancer Care Ontario, and Canadian Centre for Applied Research in Cancer Control, Toronto, ON.
PMID:
23559876
PMCID:
PMC3615855
DOI:
10.3747/co.20.1315
No abstract available